{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:01Z","timestamp":1759366501692,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.revmed.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T01:32:21Z","timestamp":1629336741000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["N\u00e9phropathie \u00e0 IgA et LGM au cours d\u2019un syndrome de S\u00e9zary"],"prefix":"10.1016","volume":"43","author":[{"given":"A.","family":"Bichon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Godefroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Farnarier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Abed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-9658","authenticated-orcid":false,"given":"N.","family":"Malissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.08.006_bib0170","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018\u00a0update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.08.006_bib0175","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.08.006_bib0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11899-016-0351-0","article-title":"S\u00e9zary syndrome: clinical and biological aspects","volume":"11","author":"Kohnken","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"10.1016\/j.revmed.2021.08.006_bib0185","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-cell lymphomas: a systematic review and meta-analysis of 16,953\u00a0patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.revmed.2021.08.006_bib0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12913-021-06109-9","article-title":"Mycosis fungoides and S\u00e9zary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016","volume":"21","author":"Keto","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.revmed.2021.08.006_bib0195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0272-6386(12)80402-1","article-title":"Glomerular disease and urinary S\u00e9zary cells in cutaneous T-cell lymphomas","volume":"21","author":"Moe","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2021.08.006_bib0200","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/archinte.1981.00340100043013","article-title":"IgA nephritis associated with mycosis fungoides. Report of two cases","volume":"141","author":"Ramirez","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2021.08.006_bib0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000084759","article-title":"Ichthyosiform mycosis fungoides: report of a case associated with IgA nephropathy","volume":"210","author":"Sato","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.revmed.2021.08.006_bib0210","first-page":"67","article-title":"A rare case of nephrotic syndrome revealing mycosis fungoide managed successfully with chemotherapy","volume":"12","author":"Kairouani","year":"2012","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.revmed.2021.08.006_bib0215","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3109\/10428190903288472","article-title":"IgA nephropathy associated with cutaneous T cell lymphoma","volume":"50","author":"Bajel","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2021.08.006_bib0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0378-6323.77459","article-title":"Ichthyosiform mycosis fungoides with alopecia and atypical membranous nephropathy","volume":"77","author":"Zhou","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CN107109","article-title":"A case of IgA nephropathy associated with mycosis fungoides that developed into rapidly progressive glomerulonephritis","volume":"79","author":"Hara","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0230","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/pgmj.66.779.773","article-title":"Immunotactoid glomerulopathy associated with mycosis fungoides","volume":"66","author":"Torrelo","year":"1990","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.revmed.2021.08.006_bib0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000187894","article-title":"Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma","volume":"67","author":"Traynor","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.revmed.2021.08.006_bib0240","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1055\/s-2008-1055460","article-title":"T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome","volume":"120","author":"Sp\u00e4th","year":"1995","journal-title":"Dtsch Med Wochenschr 1946"},{"key":"10.1016\/j.revmed.2021.08.006_bib0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000409763","article-title":"IgA mesangial nephropathy in neoplastic diseases","volume":"40","author":"Mustonen","year":"1984","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0250","doi-asserted-by":"crossref","first-page":"108347","DOI":"10.1016\/j.clim.2020.108347","article-title":"Case report on mesangial proliferative glomerulonephritis with multicentric Castleman's disease: approach to the onset mechanism of immunoglobulin A nephropathy","volume":"212","author":"Karasawa","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0255","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2215\/CJN.04820511","article-title":"Clinical features and outcomes of IgA nephropathy with nephrotic syndrome","volume":"7","author":"Kim","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10238-019-00580-9","article-title":"Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome","volume":"19","author":"Han","year":"2019","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.revmed.2021.08.006_bib0265","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/ndt\/gfr554","article-title":"Soluble interleukin-2\u00a0receptor alfa predicts renal outcome in IgA nephropathy","volume":"27","author":"Lundberg","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2021.08.006_bib0270","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0002-9343(88)90115-5","article-title":"Minimal change glomerulonephropathy and interstitial infiltration with mycosis fungoides","volume":"84","author":"Allon","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2021.08.006_bib0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3904\/kjim.1992.7.1.31","article-title":"Production of interleukin-2 (IL-2) and expression of IL-2\u00a0receptor in patients with IgA nephropathy","volume":"7","author":"Lee","year":"1992","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.revmed.2021.08.006_bib0280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2003.05224.x","article-title":"The relevance of peripheral blood T-helper 1\u00a0and 2\u00a0cytokine pattern in the evaluation of patients with mycosis fungoides and S\u00e9zary syndrome","volume":"148","author":"Papadavid","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0285","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semnephrol.2007.10.008","article-title":"Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models","volume":"28","author":"Suzuki","year":"2008","journal-title":"Semin Nephrol"},{"issue":"Suppl 6","key":"10.1016\/j.revmed.2021.08.006_bib0290","first-page":"vi52","article-title":"Secondary minimal change disease","volume":"18","author":"Glassock","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 6","key":"10.1016\/j.revmed.2021.08.006_bib0295","first-page":"vi33","article-title":"Pathology of minimal change nephropathy and segmental sclerosing glomerular disorders","volume":"18","author":"Howie","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2021.08.006_bib0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0305","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1038\/s41598-020-66040-7","article-title":"a prospective study of 309\u00a0patients followed for 12\u00a0years in a tertiary center","volume":"10","author":"Miyashiro","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2021.08.006_bib0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13045-020-01006-w","article-title":"Novel targeted therapies of T cell lymphomas","volume":"13","author":"I\u017cykowska","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0315","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mjd.2002.126247","article-title":"Increased serum immunoglobulin levels are common in mycosis fungoides and S\u00e9zary syndrome","volume":"47","author":"Talpur","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.revmed.2021.08.006_bib0320","first-page":"92","article-title":"Staging of mycosis fungoides and S\u00e9zary syndrome: time for an update\u00a0?","volume":"6","author":"Scarisbrick","year":"2018","journal-title":"EMJ Allergy Immunol"},{"key":"10.1016\/j.revmed.2021.08.006_bib0325","first-page":"57","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer 1990"},{"key":"10.1016\/j.revmed.2021.08.006_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ddg.12376","article-title":"New and established treatment options for mycosis fungoides and S\u00e9zary syndrome - an update","volume":"12","author":"Dugas-Breit","year":"2014","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321005932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321005932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:44:30Z","timestamp":1759337070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321005932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0248866321005932"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.08.006","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9phropathie \u00e0 IgA et LGM au cours d\u2019un syndrome de S\u00e9zary","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}